Effective January 1, 2018, Jeff R. Schroeder will step down from his position as Chief Commercial Officer to become President, Strategic Accounts for Oxford Immunotec Global PLC. Mr. Schroeder joined Oxford Immunotec in February 2007 and has served as the Company's Chief Commercial Officer since October 2013. Upon the effective date of this transition, Mr. Schroeder will no longer serve as an executive officer of the Company.